Ocean Biomedical, Inc. Quarterly Debt-to-equity in % from Q2 2022 to Q4 2024

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Ocean Biomedical, Inc. quarterly Debt-to-equity history and growth rate from Q2 2022 to Q4 2024.
Ocean Biomedical, Inc. Debt-to-equity for the quarter ending December 31, 2024 was -102 %, a 1.26% increase year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q4 2024	-102	+1.3	+1.26%	Dec 31, 2024
Q3 2024	-103	-0.58	-0.57%	Sep 30, 2024
Q2 2024	-103	-3.6	-3.61%	Jun 30, 2024
Q1 2024	-104	-13.6	-15.1%	Mar 31, 2024
Q4 2023	-103	-37.4	-56.7%	Dec 31, 2023
Q3 2023	-103	-56.3	-121%	Sep 30, 2023
Q2 2023	-99.8	-46	-85.4%	Jun 30, 2023
Q1 2023	-90.2			Mar 31, 2023
Q4 2022	-65.8			Dec 31, 2022
Q3 2022	-46.4			Sep 30, 2022
Q2 2022	-53.8			Jun 30, 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.